U.S. stock futures traded mostly lower this morning, with the Dow Jones futures falling around 50 points on Tuesday.
Shares of AVITA Medical, Inc. (NASDAQ:RCEL) shares dipped in pre-market trading after the company cut its FY23 revenue guidance.
AVITA Medical revised its FY23 revenue guidance from $51 million-$53 million to $49.5 million-$50.5 million, according to data from Benzinga Pro.
AVITA Medical shares fell 10.9% to $11.17 in pre-market trading
Here are some other big stocks recording losses in today’s pre-market trading session.
Now Read This: NVIDIA, Best Buy And 3 Stocks To Watch Heading Into Tuesday
Don’t forget to check out our premarket coverage here
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
